Form 4 for BSX Boston Scientific
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-18 · accession 0001225208-25-001969 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-19 | 2025-02-19 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $25.61 | +60.5K | 283.7K | +27% | +$1.55M |
| DM | 2025-02-19 | 2025-02-18+ | BSX | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $105.10 | -84.9K | 232.6K | -27% | -$8.92M |
| DM | 2025-02-19 | 2025-02-19 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | -60.5K | 31.3K | -66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | M | A | 18,533 | $24.55 | 251,151 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-19 | S | D | 67,333 | $105.24 | 225,808 | D | — | — | (F4) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $105.02 to $105.46, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-02-19 | M | A | 9,483 | $40.12 | 293,141 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-18 | S | D | 2,900 | $104.08 | 247,248 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $103.35 to $104.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2025-02-18 | S | D | 14,630 | $104.67 | 232,618 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.37 to $105.09, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2025-02-19 | M | A | 16,865 | $17.26 | 268,016 | D | — | — | |
| 7 | Common | Common Stock | 2025-02-19 | M | A | 15,642 | $27.09 | 283,658 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-02-19 | M | D | 9,483 | $0.00 | 37,934 | D | $40.12 · — to 2029-02-21 | 9,483 Common Stock | (F6) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant. |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-02-19 | M | D | 16,865 | $0.00 | 0 | D | $17.26 · — to 2026-02-22 | 16,865 Common Stock | (F7) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |
| 10 | Derivative | Stock Option (Right to Buy) | 2025-02-19 | M | D | 18,533 | $0.00 | 37,067 | D | $24.55 · — to 2027-02-28 | 18,533 Common Stock | (F8) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |
| 11 | Derivative | Stock Option (Right to Buy) | 2025-02-19 | M | D | 15,642 | $0.00 | 31,285 | D | $27.09 · — to 2028-02-15 | 15,642 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. |